Congratulations to three AlbionVC portfolio companies for being named as London's best startups to work for in 2021: each company has its own stand-out superpower and should be on every candidate’s watchlist.
Achilles Therapeutics, UCL Technology Fund portfolio company raises £52.7 million in an oversubscribed Series C round to further advance the development of personalised T cell therapies to treat solid tumours.
AlbionVC is delighted to co-lead alongside CIC a £7.1m Series A investment into Seldon, an open-source startup providing enterprises with the tools to manage, serve and optimise their machine learning models at scale.
Nozzle.ai, a UCL Technology Fund portfolio company raises $2.6m from a combination of new and existing investors to accelerate adoption of AI platform with brands and sellers on Amazon.
We are delighted to announce that AlbionVC portfolio company Aridhia together with its coalition partners today are launching Alzheimer’s Disease Data Initiative (ADDI) and Alzheimer’s disease (AD) Workbench, a cloud-based platform for scientists to accelerate discoveries and innovations for AD and related dementias.
Emil Gigov, Partner at AlbionVC reflects on the journey of Clear Review, a HR cloud solution that we had the pleasure of working with from Series A to their subsequent acquisition by Advanced.
Ed Lascelles, Partner at AlbionVC chats to Maddyness, a magazine for entrepreneurs, about investing in tech, the importance of company culture, emerging trends and much more.
AlbionVC exits Clear Review after a strategic acquisition by Advanced. AlbionVC led Clear Review's Series A investment in 2019 and today is pleased to see the company embark on the next stage of growth.
